Rare diseases
Investigational molecules
Locations
Back to Germany434 clinical trials in Kiel, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
GermanyPhase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy of Izalontamab Brengitecan versus Platinum-based Chemotherapy for Patients with EGFR-mutated Non-small Cell Lung Cancer after EGFR Inhibitor Treatment
GermanyStudy to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis
GermanyComparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes
GermanyStudy of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B
GermanyStudy of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy
GermanyStudy on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis
GermanyStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination
GermanyStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
GermanyStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
GermanyStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of ribociclib with endocrine therapy for HR-positive, HER2-negative cases. Additional research encompasses various blood cancers, including lymphomas and leukemia.
Cutting-edge research evaluating novel therapeutic combinations and treatment approaches for better patient outcomes.
Comprehensive research into chronic skin conditions, including trials for plaque psoriasis and atopic dermatitis. Studies evaluate new therapeutic agents for moderate to severe cases.
Focus on developing effective treatments for persistent skin conditions that significantly impact quality of life.
Advanced studies in inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. Trials investigate innovative therapies for moderate to severe cases.
Investigation of new therapeutic options for patients with inadequate response to conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
